Effect of aclidinium bromide/formoterol fumarate fixed-dose combination (FDC) on night-time and early morning symptoms in COPD

ConclusionsThese data suggest that aclidinium/formoterol FDC improves overall night-time and early morning symptom severity in patients with moderate to severe COPD compared with placebo and monotherapy.

Source: European Respiratory Journal - December 23, 2014 Category: Respiratory Medicine Authors: Singh, D., Chapman, K., Make, B., Mocarski, M., Serra, C., Garcia Gil, E. Tags: 5.1 Airway Pharmacology and Treatment Source Type: research